State-of-the-art management and monitoring of brain edema and intracranial hypertension in fulminant hepatic failure. A proposed algorithm

Acta Neurochirurgica, Supplementum

Volumn , Issue 106, 2009, Pages 311-314

  Gasco, Jaime ^a   Rangel Castilla, Leonardo ^a   Franklin, Brodus ^a   Thomas, Philip G ^b   Patterson, Joel T ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Brain edema; intracranial hypertension; intracranial pressure monitoring; liver failure

Indexed keywords

HYDROCORTISONE; INDOMETACIN; LIDOCAINE; MANNITOL; PROPOFOL; SODIUM CHLORIDE; THIOPENTAL;

ALGORITHM; BIOARTIFICIAL LIVER; BLOOD CLOTTING DISORDER; BRAIN EDEMA; CLINICAL DECISION MAKING; CONFERENCE PAPER; DATA BASE; ENDOTRACHEAL INTUBATION; EVIDENCE BASED PRACTICE; FULMINANT HEPATIC FAILURE; HUMAN; HYPERVENTILATION; HYPOTHERMIA; INDUCED HYPOTHERMIA; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; INTRACRANIAL PRESSURE MONITORING; LIVER FAILURE; MEDICAL LITERATURE; MEDLINE; MICRODIALYSIS; NEUROMONITORING; SEDATION; SYSTEMATIC REVIEW;

EID: 78649386709     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-98811-4_58     Document Type: Conference Paper

References (45)

1. Aggarwal S, Obrist W, Yonas H, Kramer D, Kang Y, Scott V, Planinsic R (2005) Cerebral hemodynamic and metabolic profiles in fulminant hepatic failure: relationship to outcome. Liver Transpl 11:1353-1360
2. Ascher NL, Lake JR, Emond JC, Roberts JP (1993) Liver transplantation for fulminant hepatic failure. Arch Surg 128:677-682
3. Blei AT (1991) Cerebral edema and intracranial hypertension in acute liver failure: distinct aspects of the same problem. Hepatology 13:376-379
4. Blei AT, Olafsson S, Webster S, Levy R (1993) Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 341:157-158 (Pubitemid 23029318)
5. Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R (1982) Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 23:625-629 (Pubitemid 12081117)
6. Cordoba J, Blei AT (1995) Cerebral edema and intracranial pressure monitoring. Liver Transpl Surg 1:187-194
7. Daas M, Plevak DJ, Wijdicks EF, Rakela J, Wiesner RH, Piepgras DG, Dunn WF, Steers JL (1995) Acute liver failure: results of a 5-year clinical protocol. Liver Transpl Surg 1:210-219
8. Demetriou AA, Brown RS, Jr., Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS, 2nd, Lerut J, Nyberg SL, Salizzoni M, Fagan EA, de Hemptinne B, Broelsch CE, Muraca M, Salmeron JM, Rabkin JM, Metselaar HJ, Pratt D, De La Mata M, McChesney LP, Everson GT, Lavin PT, Stevens AC, Pitkin Z, Solomon BA (2004) Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 239:660- 667; discussion 667-670
9. Detry O, Arkadopoulos N, Ting P, Kahaku E, Watanabe FD, Rozga J, Demetriou AA (1999) Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure. Am Surg 65:934-938
10. Detry O, De Roover A, Honore P, Meurisse M (2006) Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management. World J Gastroenterol 12:7405-7412
11. Donovan JP, Schafer DF, Shaw BW Jr, Sorrell MF (1998) Cerebral oedema and increased intracranial pressure in chronic liver disease. Lancet 351:719-721
12. Ede R, Gimson AE, Cannalese J, Williams R (1982) Cerebral oedema and monitoring of intracranial pressure in fulminant hepatic failure. Gastroenterol Jpn 17:163-176
13. Ede RJ, Gimson AE, Bihari D, Williams R (1986) Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 2:43-51
14. Filho JA, Machado MA, Nani RS, Rocha JP, Figueira ER, Bacchella T, Rocha-e-Silva M, Auler JO Jr, Machado MC (2006) Hypertonic saline solution increases cerebral perfusion pressure during clinical orthotopic liver transplantation for fulminant hepatic failure: preliminary results. Clinics 61:231-238
15. Forbes A, Alexander GJ, O'Grady JG, Keays R, Gullan R, Dawling S, Williams R (1989) Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure. Hepatology 10:306-310
16. Gimson AE (1996) Fulminant and late onset hepatic failure. Br J Anaesth 77:90-98
17. Hanid MA, Davies M, Mellon PJ, Silk DB, Strunin L, McCabe JJ, Williams R (1980) Clinical monitoring of intracranial pressure in fulminant hepatic failure. Gut 21:866-869
18. Helmke K, Burdelski M, Hansen HC (2000) Detection and monitoring of intracranial pressure dysregulation in liver failure by ultrasound. Transplantation 70:392-395
19. Jalan R, Olde Damink SW, Deutz NE, Davies NA, Garden OJ, Madhavan KK, Hayes PC, Lee A (2003) Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation 75:2034-2039
20. Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A (2004) Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 127:1338-1346
21. Keays R, Potter D, O'Grady J, Peachey T, Alexander G, Williams R (1991) Intracranial and cerebral perfusion pressure changes before, during and immediately after orthotopic liver transplantation for fulminant hepatic failure. Q J Med 79:425-433
22. Keays RT, Alexander GJ, Williams R (1993) The safety and value of extradural intracranial pressure monitors in fulminant hepatic failure. J Hepatol 18:205-209
23. Keays RT, Alexander GJM, Williams R (1993) The safety and value of extradural intracranial-pressure monitors in fulminant hepatic-failure. J Hepatol 18:205-209
24. Lai JC, Cooper AJ (1986) Brain alpha-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J Neurochem 47:1376-1386
25. Lai JC, Cooper AJ (1991) Neurotoxicity of ammonia and fatty acids: differential inhibition of mitochondrial dehydrogenases by ammonia and fatty acyl coenzyme A derivatives. Neurochem Res 16:795-803
26. Larsen FS (2004) Optimal management of patients with fulminant hepatic failure: targeting the brain. Hepatology 39:299-301
27. LeRoux PD, Elliott JP, Perkins JD, Winn HR (1990) Intracranial pressure monitoring in fulminant hepatic failure and liver transplantation. Lancet 335:1291-1292
28. Munoz SJ, Robinson M, Northrup B, Bell R, Moritz M, Jarrell B, Martin P, Maddrey WC (1991) Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure. Hepatology 13:209-212
29. Murphy N (2007) The pathology and management of intracranial hypertension in acute liver failure. In: Vincent J-L (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin, Heidelberg, pp 678-690
30. Murphy N, Auzinger G, Bernel W, Wendon J (2004) The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 39:464-470
31. Nakanishi K, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M, Hirano T, Hirayama Y, Moriguchi T, Watanabe E, Nitta M (2005) Intracranial pressure monitoring in patients with fulminant hepatic failure treated with plasma exchange and continuous hemodiafiltration. Blood Purif 23:113-118
32. Pugliese F, Ruberto F, Perrella SM, Cappannoli A, Bruno K, Martelli S, Celli P, Summonti D, D'Alio A, Tosi A, Novelli G, Morabito V, Poli L, Rossi M, Berloco PB, Pietropaoli P (2007) Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: case reports. Transplant Proc 39:2042-2044
33. Strauss G, Hansen BA, Knudsen GM, Larsen FS (1998) Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure. J Hepatol 28:199-203
34. Stravitz RT, Kramer AH, Davern T, Shaikh AO, Caldwell SH, Mehta RL, Blei AT, Fontana RJ, McGuire BM, Rossaro L, Smith AD, Lee WM (2007) Intensive care of patients with acute liver failure: recommendations of the US Acute Liver Failure Study Group. Crit Care Med 35:2498-2508
35. Tabernero A, Schneider F, Potenza MA, Randriamboavonjy V, Chasserot S, Wolf P, Mitolo-Chieppa D, Stoclet JC, Andriantsitohaina R (2003) Cyclooxygenase-2 and inducible nitric oxide synthase in omental arteries harvested from patients with severe liver diseases: immuno-localization and influence on vascular tone. Intensive Care Med 29:262-270
36. Tofteng F, Jorgensen L, Hansen BA, Ott P, Kondrup J, Larsen FS (2002) Cerebral microdialysis in patients with fulminant hepatic failure. Hepatology 36:1333-1340
37. Tofteng F, Larsen FS (2004) The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 24:798-804
38. Trey C, Davidson CS (1970) The management of fulminant hepatic failure. Prog Liver Dis 3:282-298
39. van de Kerkhove MP, Di Florio E, Scuderi V, Mancini A, Belli A, Bracco A, Dauri M, Tisone G, Di Nicuolo G, Amoroso P, Spadari A, Lombardi G, Hoekstra R, Calise F, Chamuleau RA (2002) Phase I clinical trial with the AMC-bioartificial liver. Int J Artif Organs 25:950-959
40. Vaquero J, Butterworth RF (2006) The brain glutamate system in liver failure. J Neurochem 98:661-669
41. Vaquero J, Chung C, Blei AT (2004) Cerebral blood flow in acute liver failure: a finding in search of a mechanism. Metab Brain Dis 19:177-194
42. Vaquero J, Fontana RJ, Larson AM, Bass NM, Davern TJ, Shakil AO, Han S, Harrison ME, Stravitz TR, Munoz S, Brown R, Lee WM, Blei AT (2005) Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 11:1581-1589
43. Volk ML, Marrero JA (2006) Advances in critical care hepatology. Minerva Anestesiol 72:269-281
44. Wendon JA, Larsen FS (2006) Intracranial pressure monitoring in acute liver failure. A procedure with clear indications. Hepatology 44:504-506
45. Wijdicks EF, Nyberg SL (2002) Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc 34: 1220-1222